Corium looks to go public for up to $50M; Researchers develop milk duct delivery method for breast cancer drugs;

> Transdermal delivery specialist Corium International filed with the Securities and Exchange Commission for an IPO expected to bring in about $50 million. Release

> A new delivery system developed at South Dakota State University is designed to deliver drugs through the milk ducts to reduce side effects and apply larger doses to affected tissue. More

> Sensile Medical completed a study for its semi-disposable patch pump for subcutaneous furosemide therapy. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.